Study of XNW28012 in Subjects With Advanced Solid Tumors Who Failed Standard Treatments

Clinical trial NCT06799637 · RECRUITING

Trial details

NCT number: NCT06799637
Sponsor: Evopoint Biosciences Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumors Pancreatic Carcinoma Ovarian Cancer Cervical Cancers

Start date: 2023-12-01
Primary completion: 2026-12-31
Enrollment: 350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.